Definitive Contract FA864920C0102
- Not listed
- The Department of the Air Force Materiel Command Research Laboratory awarded a $750,000 firm fixed price contract to Adelos, LLC under the Small Business Innovation Research Program Phase II initiative. The contract calls for Adelos to support COVID-19 research efforts through development of technologies to enhance weapon storage area perimeter security at unspecified locations. As a total small business set aside awarded through the SBIR program, the one-year contract aims to advance Adelos'...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Olink Proteomics Inc., a foreign-owned for-profit organization, in the amount of $113,936.00. The award is for the delivery of Olink's integrated fluidic circuits and reagent kits to support the Viral Pathogenesis and Evolution Section's research into the development of universal influenza and SARS-CoV-2 vaccines. The...
- The Department of the Air Force Materiel Command Research Laboratory awarded a $1.5 million Other Transaction Agreement to Aceso Plasma LLC. The contract supports COVID-19 DIB ACESO PLASMA GENERATOR-ACCELERATED WOUND HEALING AND DISINFECTION RESEARCH AND DEVELOPMENT to evaluate whether the company's plasma generator program can more effectively heal wounds and disinfect than existing technologies. Performance will take place in Virginia Beach, Virginia over 18 months through December 2021....
- This is a $249,923 firm fixed-price purchase order awarded by the Air Force Research Laboratory to Bloodstone Division LLC, a service-disabled veteran-owned small business based in Tampa, Florida. The contract is for the development of COVID-19 related medical products, including thermal insulation, vibration mitigation, and pressure injury reduction solutions for casualties. This contract is a Small Business Innovation Research (SBIR) Phase II award, indicating it is a follow-on to prior...
- This is a modification to a federal contract awarded by the Office of the Secretary of Defense to Cerus Corporation, a biomedical products company, for the LYOPHILIZED PATHOGEN REDUCED CRYOPRECIPITATE (LYO-CRYO) MANUFACTURING ADVANCEMENT PROJECT. The contract, which has a ceiling value of $24,967,786.00, is an Other Transaction Agreement with no set-aside designation. The contract supports continued development of the company's INTERCEPT Blood System, a technology that uses riboflavin and...
- This federal contract award to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, was issued by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The $19,785.63 firm-fixed-price purchase order is for Olink assay kits to enable the agency to use their existing Olink equipment and avoid the expense of having samples analyzed by Olink. This award does not have a set-aside designation. Olink Proteomics is...
- The Department of Health and Human Services Food and Drug Administration awarded a $87,620 purchase order to Olink Proteomics Inc. of Waltham, Massachusetts. The firm fixed price contract is for quantitative proteomics measurement of 100 human COVID-19 plasma samples. Performance will take place in Waltham from July 18, 2023 through December 8, 2023. The solicitation sought quantitative proteomics measurement of the specified plasma samples, as described in the attached combined synopsis and...
- This $500,000 firm fixed price contract was awarded by the United States Air Force Materiel Command Research Laboratory to D'Angelo Technologies, LLC, doing business as D'Angelo Technologies, for COVID-19 dual-purpose technologies and solutions supporting Air Force needs. The contract is being performed in Dayton, Ohio under the Small Business Innovation Research Program Phase II vehicle. It has a period of performance from June 3, 2020 through September 6, 2021 and is designated for total small...
- This federal contract award, W911QY2190008, was issued by the Joint PEO Chemical and Biological Defense, a subcomponent of the U.S. Department of the Army, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $62,096,250.00 Other Transaction Agreement is for the development of a "COVID-19" Monoclonal Antibody (MAB) Sponsorship Prototype. Resilience Government Services, a technology-focused biomanufacturing company, has previously received federal...
- The U.S. Defense Logistics Agency (DLA) awarded a $749,700.00 firm-fixed-price purchase order contract to Omnipoynt, LLC, a self-certified small disadvantaged business, to provide Accuviral viral collection kits in support of the COVID-19 response. This contract, awarded on August 24, 2020, with a completion date of October 8, 2020, was part of the DLA's medical supply chain program for the Department of Defense. Omnipoynt, LLC has been awarded over $9 million in federal contracts from the DLA...
The Department of the Air Force Materiel Command Research Laboratory awarded a small business set-aside contract to Oleolive, Inc., a for-profit biotechnology company, to develop a lyophilized (freeze-dried) platelet-rich blood product for COVID-19 response efforts. The firm-fixed-price contract has a potential value of $499,965.00 and a completion date of December 1, 2021. Oleolive, Inc. is a preclinical biotechnology company that conducts research to commercialize oleocanthal, an anti-inflammatory compound from olive oil, for use in supplements, therapeutics, and other novel applications. In addition to this COVID-19-related contract, the company has received other federal contracts and grants to support its research and development activities, including work related to cancer and Alzheimer's disease treatments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Novation Agreement | $0 | 12/30/21 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 7/22/21 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 3/10/21 | |
| Not listed | Not listed | $500.0k | 6/5/20 |